首页> 外文期刊>Dermatology: international journal for clinical and investigative dermatology >Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group.
【24h】

Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group.

机译:局部卡泊三醇联合光疗治疗牛皮癣。两项随机试验的结果以及文献综述。钙泊三醇-UVB研究组。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Calcipotrial has a well-documented effect in the treatment of psoriasis. OBJECTIVE: To confirm the beneficial effect of the combination of calcipotriol and UVB and to demonstrate that the combination is safe and well tolerated. METHODS: Data from two randomized right/left studies were analysed. Patients included in the studies had chronic stable plaque-type psoriasis with symmetrical lesions on the arms, the legs and/or the trunk. In one study, 101 patients were treated with calcipotriol on one side and calcipotriol + UVB on the other side of the body (open study). In the other study, 77 patients were treated with calcipotriol + UVB on one side and vehicle + UVB on the other side of the body (double-blind study). Calcipotriol ointment, 50 rg/g, was applied twice daily and UVB 3 times weekly for 8 weeks. UVB was increased from 0.7 MED before treatment in rapid steps up to the erythema threshold. RESULT: In both treatment series the therapeutic effect of the combination of calcipotriol and UVB was enhanced as compared to calcipotriol alone and UVB alone. In the first series there was a significant reduction of the psoriasis area and severity index (PASI) with the combination after 2 weeks as compared to calcipotriol alone. At the end of treatment significantly more sides were cleared after calcipotriol + UVB than after calcipotriol alone. In the other series there was a significantly faster onset of improvement on the sides treated with calcipotriol + UVB than on those treated with vehicle + UVB. After 2 weeks there was a significant difference in PASI in favour of calcipotriol + UVB. At the end of treatment, however, there was no difference between the treatments. There was a similar adverse event profile with either treatment. The addition of UVB to calcipotriol did not alter the tolerability or safety of topically applied calcipotriol. CONCLUSIONS: The result indicates a beneficial effect of combining calcipotriol and phototherapy. The findings are compared to other published studies.
机译:背景技术:卡泊菌素在银屑病的治疗中具有良好的疗效。目的:证实卡泊三醇和UVB组合的有益作用,并证明该组合安全且耐受性良好。方法:分析来自两个随机的右/左研究的数据。纳入研究的患者患有慢性稳定斑块型牛皮癣,在手臂,腿部和/或躯干上出现对称性病变。在一项研究中,有101位患者的一侧接受卡泊三醇治疗,另一侧接受卡泊三醇+ UVB治疗(开放研究)。在另一项研究中,有77例患者在一侧接受卡泊三醇+ UVB,在另一侧接受媒介物+ UVB(双盲研究)。每天两次卡泊三醇软膏(50 rg / g),每周3次,每次3次UVB,持续8周。 UVB从治疗前的0.7 MED迅速增加到红斑阈值。结果:与单独使用卡泊三醇和单独使用UVB相比,在两个治疗系列中卡泊三醇和UVB的联合治疗效果均得到了增强。在第一个系列中,与单独的卡泊三醇相比,两周后联合使用可使牛皮癣面积和严重程度指数(PASI)大大降低。在治疗结束时,卡泊三醇+ UVB后清除的侧面明显多于仅卡泊三醇后清除的侧面。在其他系列中,用卡泊三醇+ UVB治疗的一侧明显比用赋形剂+ UVB治疗的一侧更快地开始改善。 2周后,PASI有显着差异,而卡泊三醇+ UVB有利。然而,在治疗结束时,治疗之间没有差异。两种治疗方法都有相似的不良事件。在卡泊三醇中添加UVB不会改变局部应用卡泊三醇的耐受性或安全性。结论:该结果表明卡泊三醇与光疗相结合的有益效果。将研究结果与其他已发表的研究进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号